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Abstract
A 53-year-old male visited his primary physician for epigastric and back pain. Abdominal-enhanced computed
tomography (CT) revealed a simple cyst of the pancreatic tail attached to the stomach. A distal main pancreatic
duct (MPD) was clearly dilated, but no pancreatic tumor was identified around the stenosis of MPD by CT scan and
magnetic resonance cholangiopancreatography (MRCP). Endoscopic retrograde pancreatography (ERP) revealed
stenosis and distal dilation of the MPD located between the body and tail of the pancreas. Endoscopic ultrasound
(EUS) revealed a low density mass of 7 mm in size with distal dilation of the MPD. With the suspicion of a small
pancreatic cancer, the patient underwent distal pancreatectomy and splenectomy with lymph node dissection (D2).
On histopathological evaluation, a small pancreatic adenocarcinoma of 6 mm in size was detected around the
stenosis of MPD. Final pathological diagnosis was moderately differentiated invasive ductal adenocarcinoma of the
pancreas with no lymph node metastasis (Japan Pancreatic Society (JPS) classification 7th edition; Pbt, TS1 (6 mm),
tub2, intermediate type, INF β, ly1, v1, ne1, mpd(-), pT1b, pN0, pM0, stage IA,PCM(-), DCM(-) and the Union
International Control Cancer (UICC) classification of malignant tumors 6th edition; pT1, pN0, pM0, stage IA, R0). We
herein reported a patient who underwent radical resection for T1 pancreatic adenocarcinoma of 6 mm in diameter
which caused acute pancreatitis and a pseudocyst due to obstruction of the MPD.
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Background
Pancreatic cancer is one of the most frequent malignant
tumors in the world. An overall survival rate remains
poor because of advanced stage at the time of diagnosis,
and rapid tumor growth despite the improvement in im-
aging studies [1]. Surgical cases of tumor factor 1 (T1)
in patients with pancreatic cancer are rare which are
2.95% in the literature, of which the tumors less than
10 mm in size account for only 0.55% in patients with
resectable pancreatic cancer [2]. We herein reported a
radical resection of patients with a 6 mm T1 pancreatic
adenocarcinoma which prevented clinically as a pseudo-
cyst due to obstructive acute pancreatitis.
Case presentation
A 53-year-old male visited his primary physician for epi-
gastric and back pain. He had neither a family history of
pancreatic cancer nor a history of alcohol as well as
smoking. On laboratory examinations, the levels of
serum pancreatic amylase, C-reactive protein (CRP), and
carcinoembryonic antigen (CEA) were up to 250 U/l,
2.1 mg/dl, and 10.2 ng/ml, respectively. Serum carbody-
drate antigen 19-9 (CA19-9), DUPAN-2, and immuno-
globulin G4 (IgG4) were within normal limits.
Abdominal-enhanced computed tomography (CT) re-
vealed a simple cyst of the pancreatic tail attached to the
stomach (Fig. 1). The distal MPD was clearly dilated, but
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no pancreatic tumor was detectable around the stenosis
of MPD by CT scan and magnetic resonance cholangio-
pancreatography (MRCP) (Fig. 2). Endoscopic retrograde
pancreatography (ERP) revealed stenosis and distal dila-
tion of the MPD located at transition between the body
and tail of the pancreas. The MPD of the pancreatic
head was smooth. Endoscopic ultrasound (EUS) revealed
a low density mass of 7 mm in size in the pancreatic
body with distal dilation of the MPD, but fine needle as-
piration of the mass was not performed because of the
small size and the risk of dissemination of cancer cells
(Fig. 3a). After insertion of an endoscopic nasopancreatic
drainage (ENPD) tube over the stenosis of MPD (Fig. 3b),
the symptoms of the patient disappeared and the size of
the pseudocyst was obviously reduced. The cytology of
pancreatic juice was performed three times and was
negative for malignancy (class II). With a suspicion of an
early staged pancreatic cancer, the patient underwent
distal pancreatectomy and splenectomy with lymph node
dissection (D2). Intraoperatively, there was a severe ad-
hesion encountered between the stomach and the
pseudocyst. The pancreatic mass was not detected by in-
traoperative ultrasound. The line of pancreatic resection
was above the superior mesenteric vein (SMV). Oper-
ation time and intraoperative bleeding were 275 min and
557 ml, respectively. Perioperative transfusion was not
used (Fig. 4).
On histopathological evaluation, the small pancreatic
adenocarcinoma of 6 mm in size was detected near the
stenotic MPD. The obvious cancer cell invasion around
the tumor was not detected but an invasion to the small
veins (v1) and lymphatic ducts (ly1) as well as small
neural infiltration (ne1) were present. Final pathological
staging was moderately differentiated invasive ductal
adenocarcinoma of the pancreas with no lymph node
metastasis (Japan Pancreatic Society (JPS) classification
7th edition; Pbt, TS1 (6 mm), tub2, intermediate type,
INF β, ly1, v1, ne1, mpd(-), pT1b, pN0, pM0, stage
IA,PCM(-), DCM(-) and the Union International Con-
trol Cancer (UICC) classification of malignant tumors
6th edition; pT1, pN0, pM0, stage IA, R0). The resection
margins were fine of cancer involvement. The patient
developed surgical site infection and chylous ascites, and
the patient was discharged on postoperative day 53. The
patient will receive an adjuvant chemotherapy with TS-1
for 6 months.
Conclusions
Previously, a small tumor (<2 cm in diameter) was a
good prognotic factor in patients with pancreatic cancer
for the first time in 1964 [3]. Therefore, the tumor size
(TS) was categorized by the criteria of the JPS as TS1,
<2 cm; TS2, 2.1–4.0 cm; TS3, 4.1–6.0; or TS4, >6.0 cm.
However, the rates of T1 and stage I in the JPS classifica-
tion in all patients with TS1 pancreatic cancer were only
21.6 and 14.9%, respectively, because of locally advanced
tumor invasion. Moreover, the rate of lymph node me-
tastases was 46.1% in patients with TS1 pancreatic can-
cer [2]. Therefore, the TS may not reflect prognosis in
patients with pancreatic cancer. Other investigators sug-
gested that the small pancreatic ductal adenocarcinoma
(<1.0 cm in diameter) or carcinoma in situ was a good
postoperative prognosis, thus categorized as early pan-
creatic cancers [4]. The rates of early pancreatic cancer,
TS1 pancreatic cancer, or stage I pancreatic cancer in
Fig. 1 Abdominal-enhanced CT image of the pancreatic lesion. A simple cyst of the pancreatic tail was attached to the stomach, and the wall of
the cyst was enhanced (arrows). A distal MPD was clearly dilated, but no pancreatic tumor was detectable around the stenosis of MPD (arrow)
Fig. 2 MRCP revealed a simple cyst of the pancreatic tail like CT
images (arrow). No pancreatic tumor could be detected around the
stenosis of MPD. The distal MPD was not clearly visualized (arrow)
Fujiwara et al. Surgical Case Reports  (2016) 2:144 Page 2 of 4
patients with all resectable pancreatic cancers were 0.55,
4.05, or 27%, respectively [2]. However, a significant dif-
ference of prognosis between an early pancreatic cancer
and other stage I pancreatic cancers with a tumor diam-
eter of 1–2 cm had not been reported because of the
small numbers of patients.
Tumor markers such as CEA and CA19-9 are very
useful tools to screen for detection and recurrences of
malignant diseases. Although about 80% of patients with
pancreatic cancer are positive for serum CA19-9, mostly
in advanced stages, false-positive rates are very high
(20–30%) in patients with beginning hepatobiliary-
pancreatic diseases [5]. The estimation of CEA and
CA19-9 may not be useful to diagnosis as pancreatic
cancer at an early stage. However, in the current case,
the preoperative serum CEA was slightly increased.
After distal pancreatectomy, serum CEA decreased to
normal limits. In this case, the reason of preoperative
elevation with serum CEA seemed to be caused by the
pancreatic pseudocyst of the tail.
The microscopic invasion of the lymph ducts and ves-
sels in patients with pancreatic cancer is associated with
significantly poor prognosis because of high T stage, ab-
sent lymph node metastasis, and perineural invasion [6].
However, a significance of microscopic invasion of the
lymph ducts and vessels in patients with pancreatic can-
cer in stage I remains unclear.
The diagnosis of early pancreatic tumor is still difficult
despite the development of CT, MRI, and endoscopic
ultrasound (EUS). MRI offers several benefits for im-
aging of the pancreas. In particular, MRCP obtained with
long echo times on T2-weighted MR images may help to
Fig. 3 a EUS revealed a low density mass of 7 mm in size in the pancreatic body. b Endoscopic retrograde pancreatography (ERP) revealed
stenosis and distal dilation of the MPD between the body and tail of the pancreas (arrow)
Fig. 4 a On macroscopic findings, the distal MPD was obviously dilated, but the tumor could not be detected around the stenotic MPD. b, c, d
In microscopic views, the pancreatic tumor of 7 mm in size was detected. The tumor cells were localized with proliferation of fibroblast cells in
the framework. Pathological features in H&E stain
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demonstrate the pancreatic ductal systems and detect
small pancreatic tumors. However, the differentiation
between small pancreatic cancer and pancreatitis is
still difficult on T1-weighted and T2-weighted MR
images [7]. The preoperative indication of ERCP ex-
cept for a biliary drainage has been declining because
of the development of MRCP. However, ERCP seems
a very useful examination to detect stenosis of the
MPD in patients with small pancreatic cancer com-
bined with inflammation as compared with MRCP
[8]. In the current case, ERCP clearly detected the
local stenosis of the MPD and the normal smooth
MPD of the pancreatic head which suggested the
negative suspicion of a pancreatitis. Therefore, diag-
nostic ERCP seems still valuable if a tumor is sus-
pected despite the negative results on other images or
differentiation between inflammation and cancer. EUS
is reported to be superior to CT, MRI, and PET in
the detection of small tumors in the pancreas and
lymph node metastases as well as invasion of the
major artery [9]. The typical features of pancreatic
cancer was seen by EUS as a hypoechoic mass with
irregular borders compared with normal pancreatic
tissue. EUS-guided fine needle aspiration (EUS-FNA)
is also a safe and highly accurate method for a
pathological diagnosis of a tumor. However, the dis-
advantage of EUS as well as EUS-FNA is that the ac-
curacy and sensitivity of these examinations depend
on the technique of the operators. As a result, to de-
tect small pancreatic tumors and for differential
diagnosis of pancreatic cancer and pancreatitis, we
need to consider the advantage and disadvantage of
each image modality.
Nakamura T et al. [10] was reported to perform
pancreaticoduodenectomy in patients with pancreatic
cancer less than 1 cm in a diameter. The case was
not any symptoms but incidentally serum CA19-9 ele-
vation. To our knowledge, this is the first resectable
case of such a small pancreatic cancer less than 1 cm
in a diameter with complication of acute pancreatitis
and formation of a pseudocyst due to obstruction of
the MPD.
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